文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

1型糖尿病患者在体育活动和运动期间使用自动胰岛素输注：欧洲糖尿病研究协会（EASD）和国际儿童及青少年糖尿病学会（ISPAD）的立场声明

The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD).

作者信息

Moser Othmar, Zaharieva Dessi P, Adolfsson Peter, Battelino Tadej, Bracken Richard M, Buckingham Bruce A, Danne Thomas, Davis Elizabeth A, Dovč Klemen, Forlenza Gregory P, Gillard Pieter, Hofer Sabine E, Hovorka Roman, Jacobs Peter G, Mader Julia K, Mathieu Chantal, Nørgaard Kirsten, Oliver Nick S, O'Neal David N, Pemberton John, Rabasa-Lhoret Rémi, Sherr Jennifer L, Sourij Harald, Tauschmann Martin, Yardley Jane E, Riddell Michael C

机构信息

Department of Exercise Physiology and Metabolism (Sportsmedicine), University of Bayreuth, Bayreuth, Germany.

Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.

出版信息

Diabetologia. 2025 Feb;68(2):255-280. doi: 10.1007/s00125-024-06308-z.

DOI:10.1007/s00125-024-06308-z
PMID:39653802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11732933/
Abstract

Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved the ability of people with type 1 diabetes to achieve the recommended glucose target ranges. PA provide additional health benefits but can cause glucose fluctuations, which challenges current AID systems. While an increasing number of clinical trials and reviews are being published on different AID systems and PA, it seems prudent at this time to collate this information and develop a position statement on the topic. This joint European Association for the Study of Diabetes (EASD)/International Society for Pediatric and Adolescent Diabetes (ISPAD) position statement reviews current evidence on AID systems and provides detailed clinical practice points for managing PA in children, adolescents and adults with type 1 diabetes using AID technology. It discusses each commercially available AID system individually and provides guidance on their use in PA. Additionally, it addresses different glucose responses to PA and provides stratified therapy options to maintain glucose levels within the target ranges for these age groups.

摘要

规律的体育活动和锻炼（PA）是1型糖尿病患者糖尿病护理的基石。近年来，自动胰岛素输送（AID）系统的出现提高了1型糖尿病患者实现推荐血糖目标范围的能力。体育活动能带来额外的健康益处，但会导致血糖波动，这对当前的AID系统构成了挑战。虽然关于不同AID系统和体育活动的临床试验和综述越来越多，但此时整理这些信息并就该主题发表一份立场声明似乎是明智的。这份欧洲糖尿病研究协会（EASD）/国际儿科和青少年糖尿病学会（ISPAD）联合立场声明回顾了关于AID系统的现有证据，并为使用AID技术管理1型糖尿病儿童、青少年和成人的体育活动提供了详细的临床实践要点。它分别讨论了每种商用AID系统，并就其在体育活动中的使用提供了指导。此外，它阐述了对体育活动的不同血糖反应，并提供了分层治疗方案，以将这些年龄组的血糖水平维持在目标范围内。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/374969fb0e5e/125_2024_6308_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/246e0f372853/125_2024_6308_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/cc1029e2f5d0/125_2024_6308_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/d13aa5f6bfc6/125_2024_6308_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/eec79769fde1/125_2024_6308_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/604d1bd9db00/125_2024_6308_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/4c4388252480/125_2024_6308_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/4e320e35b209/125_2024_6308_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/47606cd16806/125_2024_6308_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/50ec376f19c5/125_2024_6308_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/0f4d15dd36d1/125_2024_6308_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/53d0a2e441a2/125_2024_6308_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/374969fb0e5e/125_2024_6308_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/246e0f372853/125_2024_6308_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/cc1029e2f5d0/125_2024_6308_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/d13aa5f6bfc6/125_2024_6308_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/eec79769fde1/125_2024_6308_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/604d1bd9db00/125_2024_6308_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/4c4388252480/125_2024_6308_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/4e320e35b209/125_2024_6308_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/47606cd16806/125_2024_6308_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/50ec376f19c5/125_2024_6308_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/0f4d15dd36d1/125_2024_6308_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/53d0a2e441a2/125_2024_6308_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf3f/11732933/374969fb0e5e/125_2024_6308_Fig12_HTML.jpg

相似文献

[1]
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD).

Diabetologia. 2025-2

[2]
The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD).

Horm Res Paediatr. 2024-12-10

[3]
Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).

Pediatr Diabetes. 2020-12

[4]
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies - Insulin Delivery.

Horm Res Paediatr. 2024

[5]
Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).

Diabetologia. 2020-12

[6]
An evaluation of how exercise position statement guidelines are being used in the real world in type 1 diabetes: Findings from the type 1 diabetes exercise initiative (T1DEXI).

Diabetes Res Clin Pract. 2024-11

[7]
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring.

Horm Res Paediatr. 2024

[8]
Automated Insulin Delivery Systems in Pediatric Type 1 Diabetes: A Narrative Review.

J Diabetes Sci Technol. 2024-11

[9]
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.

Diabetologia. 2015-3-18

[10]
Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.

Diabetes Technol Ther. 2018-7-6

引用本文的文献

[1]
Editorial: Continuous glucose monitoring: beyond diabetes management.

Front Endocrinol (Lausanne). 2025-8-21

[2]
Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial.

Diabetes Care. 2025-9-1

[3]
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems.

J Diabetes Sci Technol. 2025-7

[4]
Glycaemic impact of the pre-exercise timing of an elevated glucose target implemented using an automated insulin delivery system in adults with type 1 diabetes.

Diabetes Obes Metab. 2025-9

[5]
Use of the temporary glycemic target feature in the medtronic MiniMed™ 780G advanced hybrid closed loop system: a real-world evidence study.

Acta Diabetol. 2025-6-5

[6]
CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes.

Cardiovasc Diabetol. 2025-5-2

[7]
Management and Medical Care for Individuals with Type 1 Diabetes Running a Marathon.

J Clin Med. 2025-4-6

[8]
Applications and prospects of biomaterials in diabetes management.

Front Bioeng Biotechnol. 2025-3-7

[9]
Editorial: Diabetes complications in children and adolescents: from low-resource to technology-advanced countries.

Front Med (Lausanne). 2025-2-20

本文引用的文献

[1]
The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors.

J Diabetes Sci Technol. 2024-11

[2]
Safety of Options to "Boost" (Enhancing Insulin Infusion Rates) and "Ease-Off" (Reducing Insulin Infusion Rates) in CamAPS FX Hybrid Closed-Loop System: A Real-World Analysis.

Diabetes Technol Ther. 2025-1

[3]
Automated Insulin Delivery Systems in Pediatric Type 1 Diabetes: A Narrative Review.

J Diabetes Sci Technol. 2024-11

[4]
Predicting Hypoglycemia and Hyperglycemia Risk During and After Activity for Adolescents with Type 1 Diabetes.

Diabetes Technol Ther. 2024-10

[5]
Factors Affecting Reproducibility of Change in Glucose During Exercise: Results From the Type 1 Diabetes and EXercise Initiative.

J Diabetes Sci Technol. 2024-3-8

[6]
Online Classification of Unstructured Free-Living Exercise Sessions in People with Type 1 Diabetes.

Diabetes Technol Ther. 2024-10

[7]
Development and Future of Automated Insulin Delivery (AID) Systems.

Diabetes Technol Ther. 2024-3

[8]
Exercising Safely with the MiniMed™ 780G Automated Insulin Delivery System.

Diabetes Technol Ther. 2024-3

[9]
(Hybrid) Closed-Loop Systems: From Announced to Unannounced Exercise.

Diabetes Technol Ther. 2023-12-22

[10]
Performance of Tandem Control IQ During Outdoor Physical Activity in Children and Adolescents with Type 1 Diabetes.

Diabetes Technol Ther. 2024-2

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索